Please assess the completion status of the following clinical trial:

Trial Title: LESCOD: Lewy Body Screening in Cognitive Disorders

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Be a woman or a male \>60 to \< 90 years~* Have sufficient visual and auditory acuity~* Be able to speak, read, hear and understand french language~* Be covered by health care insurance~* Have a reliable help/partner/informant/caregiver~* Have a mild to severe cognitive decline based on MMSE (Mini-Mental State Examination) score ( From 18 to 26)~* Give oral agreement to the assessment of the LEsCoD scale during routine consultation~* Have performed neuropsychology tests and MRI respectively within 6 and 12 months~Exclusion Criteria:~* Has evidence of neurological or psychiatric disorder other than AD or DLB explaining cognitive decline~* Has received previously or currently neuroleptic treatment~* Has no reliable help/caregiver the day of the visit~* Refuses to give his/her oral agreement to the assessment of the LeSCoD scale~* Has presence on MRI of radiologic evidence of cerebrovascular disease (score Fazekas 2)

- Gender: ALL
- Minimum Age: 60 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- Alzheimer disease (AD) (Type: OTHER): Patients with AD according to NINCDS-ADRDA (National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association) criteria Intervention: LeSCoD scale
- Dementia with Lewy Bodies (DLB) (Type: OTHER): Patients with probable DLB according to McKeith criteria. Intervention: LeSCoD scale
- Probable AD and possible DLB (Type: OTHER): Patients with clinical criteria for possible or probable AD and possible DLB Intervention: LeSCoD scale

Based on this trial design, predict the completion outcome and termination type (if applicable).